CD209 and neoplasm: However, several C-type lectins, such as DC-SIGN, CLEC14A, macrophage galactose C-type lectin (MGL) contribute to tumor progression inducing immunosuppressive responses by sensing abnormal or altered tumor-associated carbohydrates [110].